Document is current
Any future updates will be listed below
-
Authors
Rami-Merhar, Birgit
- License Information
-
More Information
Article History
Accepted: 3 September 2024
First Online: 28 October 2024
Interessenkonflikt
: B. Rami-Merhar erhielt Vortragshonorare von Abbott Diabetes Care, Dexcom, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Sanofi und Menarini und war Mitglied in Beratungsgremien von Eli Lilly, Dexcom, Roche Diabetes Care, Sanofi und Abbott Diabetes Care.
Free to read: This content has been made available to all.
